Enzo Biochem, Inc. (ENZ)

zzlangerhans (99.34) Submitted: 11/08/08 8:02 PM : Start Price: $6.17 ENZ Score: -16.96

Enzo stock seems to have stabilized from its recent precipitous decline. The severity of the drop is only matched in mysteriousness by the ascent to 15 over the summer without any clear precipitant. My main complaint about Enzo remains the same - slow progress in the pipeline with confusing guidance about expected timing of completion of trials. However, it is hard to ignore a company generating 20M of revenue per quarter at this market cap, even though they continue to operate at a slight loss. I think Enzo may trade range-bound for a while, and is likely at the lower end of range now. Of course, nothing the stock has done has made sense for a year, so why am I still writing this pitch?

Report this Post Replies: 0 | Reply | Permalink